Epigenetic analysis via pyromark sequencing of 32 CpGs of the RASSF1A promoter region revealed that IBC patients have a higher percentage of CpG methylation in comparison to breast reduction surgery (BRS) patients (normal control) [67]. The gene discussed is RASSF1; the disease is inflammatory breast carcinoma.